NovaBridge Biosciences (FRA:0VY)
Germany · Delayed Price · Currency is EUR 2.080
-0.080 (-3.70%)
Last updated: Apr 24, 2026, 8:04 AM CET
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of €243.86 million as of April 24, 2026. Its market cap has increased by 375.86% in one year.
Market Cap
243.86M
Enterprise Value
66.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.08
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from 124.45M to 243.86M, an increase of 95.95%. That is a compound annual growth rate of 11.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 243.86M | -37.60% |
| Dec 31, 2025 | 390.81M | 484.53% |
| Dec 31, 2024 | 66.86M | -53.13% |
| Dec 29, 2023 | 142.66M | -56.11% |
| Dec 30, 2022 | 325.02M | -89.87% |
| Dec 31, 2021 | 3.21B | 18.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.45B |
| Darwin AG | 92.40M |
| 2invest AG | 49.36M |
| Biomark Diagnostics | 35.52M |
| co.don AG | 374.13K |
| Paion AG | 285.35K |
| bioXXmed AG | 244.68K |
| MagForce AG | 76.43K |